New patent for Santen drug OMLONTI

Annual Drug Patent Expirations for OMLONTI Omlonti is a drug marketed by Santen and is included in one NDA. It is available from one supplier. There are nine patents protecting…

The post New patent for Santen drug OMLONTI appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog